Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU MARCHE DEJEAN : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU MARCHE DEJEAN is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75018), this company of category PME shows in 2020 a net income positive of 336 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DU MARCHE DEJEAN (SIREN 484202924)
Indicator 2020 2019
Revenue N/C N/C
Net income 336 275 € 26 856 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2020, SELARL PHARMACIE DU MARCHE DEJEAN generates positive net income of 336 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2020: 27 k€ -> 336 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

336 275 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.404%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.441%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

20.0%

Solvency indicators evolution
SELARL PHARMACIE DU MARCHE DEJEAN

Sector positioning

Debt ratio
3.4 2020
2019
2020
Q1: 33.2
Med: 96.78
Q3: 238.43
Excellent

In 2020, the debt ratio of SELARL PHARMACIE DU MARCH... (3.40) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
45.44% 2020
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.95%
Good

In 2020, the financial autonomy of SELARL PHARMACIE DU MARCH... (45.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 148.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

148.165

Liquidity indicators evolution
SELARL PHARMACIE DU MARCHE DEJEAN

Sector positioning

Liquidity ratio
148.16 2020
2019
2020
Q1: 133.12
Med: 181.89
Q3: 251.9
Average

In 2020, the liquidity ratio of SELARL PHARMACIE DU MARCH... (148.16) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL PHARMACIE DU MARCHE DEJEAN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of SELARL PHARMACIE DU MARCHE DEJEAN is estimated at 4 752 459 € (range 3 168 873€ - 6 412 350€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
3168k€ 4752k€ 6412k€
4 752 459 € Range: 3 168 873€ - 6 412 350€
NAF 5 année 2020

Valuation method used

Net Income Multiple
336 275 € × 14.1x = 4 752 460 €
Range: 3 168 873€ - 6 412 351€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU MARCHE DEJEAN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU MARCHE DEJEAN

What is the revenue of SELARL PHARMACIE DU MARCHE DEJEAN ?

The revenue of SELARL PHARMACIE DU MARCHE DEJEAN is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DU MARCHE DEJEAN profitable?

Yes, SELARL PHARMACIE DU MARCHE DEJEAN generated a net profit of 336 k€ in 2020.

Where is the headquarters of SELARL PHARMACIE DU MARCHE DEJEAN ?

The headquarters of SELARL PHARMACIE DU MARCHE DEJEAN is located in PARIS (75018), in the department Paris.

Where to find the tax return of SELARL PHARMACIE DU MARCHE DEJEAN ?

The tax return of SELARL PHARMACIE DU MARCHE DEJEAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU MARCHE DEJEAN operate?

SELARL PHARMACIE DU MARCHE DEJEAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.